Clinical Trial Update: PHOspholamban RElated CArdiomyopathy STudy - Intervention [Phase 3]

View source ↗

Summary

A Phase 3 trial on Phospholamban R14del Mutation-related Cardiomyopathy has completed recruitment and status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phospholamban R14del Mutation-related Cardiomyopathy

Snippet

Sponsor: M.p. van den Berg, MD, PhD, professor in Cardiology | Conditions: Phospholamban R14del Mutation-related Cardiomyopathy | Phase 3 | Status: COMPLETED